TAUNS Laboratories, Zacros Form Alliance for Next-Gen Point-of-Care Testing Devices

MT Newswires Live

2025/02/07

TAUNS Laboratories (TYO:197A) has entered into a strategic alliance with Zacros Corp. to develop and manufacture components for next-generation point-of-care testing devices, according to a Thursday filing on the Tokyo Stock Exchange.

The partnership integrates TAUNS' expertise in rapid diagnostic test kits with Zacros' biochip technology, aiming to improve diagnostic functionality and production efficiency.

The collaboration will focus on expanding applications for POCT devices and enhancing rapid test kits for infectious diseases.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2509515733"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2509515733\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2509515733?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-07 06:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2509515733","market":"nz","top_or_hot":-1,"title":"TAUNS Laboratories, Zacros Form Alliance for Next-Gen Point-of-Care Testing Devices","media":"MT Newswires Live","content":"<html><body><p> TAUNS Laboratories (TYO:197A) has entered into a strategic alliance with Zacros Corp. to develop and manufacture components for next-generation point-of-care testing devices, according to a Thursday filing on the Tokyo Stock Exchange.</p><p>The partnership integrates TAUNS' expertise in rapid diagnostic test kits with Zacros' biochip technology, aiming to improve diagnostic functionality and production efficiency.</p><p>The collaboration will focus on expanding applications for POCT devices and enhancing rapid test kits for infectious diseases.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TAUNS Laboratories, Zacros Form Alliance for Next-Gen Point-of-Care Testing Devices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTAUNS Laboratories, Zacros Form Alliance for Next-Gen Point-of-Care Testing Devices\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-07 06:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> TAUNS Laboratories (TYO:197A) has entered into a strategic alliance with Zacros Corp. to develop and manufacture components for next-generation point-of-care testing devices, according to a Thursday filing on the Tokyo Stock Exchange.</p><p>The partnership integrates TAUNS' expertise in rapid diagnostic test kits with Zacros' biochip technology, aiming to improve diagnostic functionality and production efficiency.</p><p>The collaboration will focus on expanding applications for POCT devices and enhancing rapid test kits for infectious diseases.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2509515733","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2509515733","pubTimestamp":1738882565,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"TAUNS Laboratories  has entered into a strategic alliance with Zacros Corp. to develop and manufacture components for next-generation point-of-care testing devices, according to a Thursday filing on the Tokyo Stock Exchange.The partnership integrates TAUNS' expertise in rapid diagnostic test kits with Zacros' biochip technology, aiming to improve diagnostic functionality and production efficiency.The collaboration will focus on expanding applications for POCT devices and enhancing rapid test kits for infectious diseases.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4097":"系统软件","BK4585":"ETF&股票定投概念","GEN":"GEN DIGITAL INC","LU2286300806.USD":"Allianz Cyber Security AT Acc USD"},"translate_title":"TAUNS Laboratories与Zacros结成下一代护理点测试设备联盟","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GEN":1},"content_text":"TAUNS Laboratories (TYO:197A) has entered into a strategic alliance with Zacros Corp. to develop and manufacture components for next-generation point-of-care testing devices, according to a Thursday filing on the Tokyo Stock Exchange.The partnership integrates TAUNS' expertise in rapid diagnostic test kits with Zacros' biochip technology, aiming to improve diagnostic functionality and production efficiency.The collaboration will focus on expanding applications for POCT devices and enhancing rapid test kits for infectious diseases.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}